ALTACE 1.25 mg MP (Altace 1.25 mg)
Generic Name: ramipril
Pill with imprint ALTACE 1.25 mg MP is Yellow, Capsule-shape and has been identified as Altace 1.25 mg. It is supplied by Monarch Pharmaceuticals, Inc..
Altace is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; heart failure; cardiovascular risk reduction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Altace 1.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ALTACE 1.25 mg MP
Altace
- Generic Name
- ramipril
- Imprint
- ALTACE 1.25 mg MP
- Strength
- 1.25 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Monarch Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61570-0110
- Inactive Ingredients
-
corn starch,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Altace (ramipril)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 10 Reviews
- Generic Availability
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.